• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与经组织病理学诊断为肝细胞癌的犬存活相关的因素:94 例病例报告(2007-2018 年)。

Factors associated with survival in dogs with a histopathological diagnosis of hepatocellular carcinoma: 94 cases (2007-2018).

机构信息

Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14850, USA.

出版信息

Open Vet J. 2021 Jan-Mar;11(1):144-153. doi: 10.4314/ovj.v11i1.21. Epub 2021 Feb 23.

DOI:10.4314/ovj.v11i1.21
PMID:33898296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8057222/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer in dogs. Despite this, relatively few reports of this disease exist pertaining to prognostic factors and outcome.

AIM

To evaluate factors associated with survival in dogs with all subtypes of HCC diagnosed on histopathology.

METHODS

A retrospective single institutional study was carried out on 94 client-owned dogs with a histopathologic diagnosis of HCC between 2007 and 2018 obtained by biopsy (21/94) or attempted definitive resection (73/94). Signalment, preoperative features, surgical findings, and postoperative outcomes were recorded. Associations between survival to discharge data were collected and univariable logistical regression was carried out. Kaplan-Meier survival analysis was carried out to identify negative risk factors for long-term prognosis.

RESULTS

The median survival time (MST) for all patients was 707 days (95% CI = 551-842). MST was not significantly different ( > 0.05) between patients who had suspected versus incidentally diagnosed HCC (695 775 days), between complete versus incomplete surgical margins (668 834 days), or between patients with massive subtype versus nodular/diffuse subtype (707 747 days). Logistical regression identified an association with the excision of the right medial lobe and risk of perioperative death (OR = 9.2, CI 1.5-55.9, = 0.016). An American Society of Anesthesiologists score ≥4, disease present within the quadrate lobe, and elevated blood urea nitrogen, potassium or gamma-glutamyltransferase were identified as negative prognosticators during multivariable Cox regression. Preoperative imaging (ultrasound or CT) agreed with the surgical location in 91% of the cases. Preoperative cytology was consistent with a diagnosis of HCC in 15/32 (46.9%) cases.

CONCLUSION

Type of diagnosis (incidental vs presumed), completeness of excision, and subtype were not associated with MST in this study. Preoperative identification of tumors within the central division may be related to a less favorable outcome. Results of preoperative cytology were not highly sensitive for identifying a malignancy.

摘要

背景

肝细胞癌(HCC)是犬原发性肝癌中最常见的形式。尽管如此,关于这种疾病的预后因素和结果的报告相对较少。

目的

评估组织病理学诊断为所有亚型 HCC 的犬生存相关因素。

方法

对 2007 年至 2018 年间通过活检(21/94)或尝试明确切除(73/94)获得组织病理学诊断为 HCC 的 94 只患犬进行回顾性单机构研究。记录了犬的一般情况、术前特征、手术发现和术后结果。收集了与存活至出院数据的相关性,并进行了单变量逻辑回归分析。进行 Kaplan-Meier 生存分析以确定对长期预后的不利风险因素。

结果

所有患者的中位生存时间(MST)为 707 天(95%CI=551-842)。疑似 HCC 与偶然诊断 HCC 之间(695-775 天)、完全切除与不完全切除之间(668-834 天)以及巨块型与结节/弥漫型之间(707-747 天)的 MST 差异无统计学意义(>0.05)。逻辑回归确定与右内侧叶切除和围手术期死亡风险相关(OR=9.2,CI 1.5-55.9,=0.016)。多变量 Cox 回归分析确定美国麻醉师协会评分≥4、疾病位于方叶、血尿素氮、钾或γ-谷氨酰转移酶升高为负预后因素。术前影像学(超声或 CT)在 91%的病例中与手术部位一致。术前细胞学检查与 HCC 诊断一致的有 15/32(46.9%)例。

结论

在本研究中,诊断类型(偶然发现与推测)、切除的完整性和亚型与 MST 无关。术前识别中央部肿瘤可能与预后较差相关。术前细胞学检查对识别恶性肿瘤的敏感性不高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/1d7700bc35c0/OpenVetJ-11-144-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/3fa77c325769/OpenVetJ-11-144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/b3ea382218c4/OpenVetJ-11-144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/0d52a0afb501/OpenVetJ-11-144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/905683fb0e70/OpenVetJ-11-144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/1d7700bc35c0/OpenVetJ-11-144-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/3fa77c325769/OpenVetJ-11-144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/b3ea382218c4/OpenVetJ-11-144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/0d52a0afb501/OpenVetJ-11-144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/905683fb0e70/OpenVetJ-11-144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/8057222/1d7700bc35c0/OpenVetJ-11-144-g005.jpg

相似文献

1
Factors associated with survival in dogs with a histopathological diagnosis of hepatocellular carcinoma: 94 cases (2007-2018).与经组织病理学诊断为肝细胞癌的犬存活相关的因素:94 例病例报告(2007-2018 年)。
Open Vet J. 2021 Jan-Mar;11(1):144-153. doi: 10.4314/ovj.v11i1.21. Epub 2021 Feb 23.
2
Impact of surgical margins on survival of 37 dogs with massive hepatocellular carcinoma.手术切缘对37只患有巨大肝细胞癌犬类生存的影响。
N Z Vet J. 2017 Sep;65(5):227-231. doi: 10.1080/00480169.2017.1319304. Epub 2017 May 8.
3
Outcomes and prognostic variables associated with central division hepatic lobectomies: 61 dogs.与肝中叶切除术相关的结果和预后变量:61只犬。
Vet Surg. 2019 Apr;48(3):309-314. doi: 10.1111/vsu.13164. Epub 2019 Jan 20.
4
Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case-control study.复发性巨大肝细胞癌犬的风险因素和预后:兽医外科肿瘤学会病例对照研究。
Vet Comp Oncol. 2022 Sep;20(3):697-709. doi: 10.1111/vco.12824. Epub 2022 May 15.
5
Histopathologic findings and survival outcomes of dogs undergoing liver lobectomy as treatment for spontaneous hemoabdomen secondary to a ruptured liver mass: retrospective analysis of 200 cases (2012-2020).对因肝破裂导致自发性血腹而行肝叶切除术的犬的组织病理学发现和生存结果进行回顾性分析:200 例病例(2012-2020 年)。
J Am Vet Med Assoc. 2022 Nov 10;261(2):237-245. doi: 10.2460/javma.22.03.0130.
6
Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.多期肝脏 MRI 用于识别肝细胞癌的巨梁型-巨块型亚型。
Radiology. 2020 Jun;295(3):562-571. doi: 10.1148/radiol.2020192230. Epub 2020 Mar 31.
7
The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.肝细胞癌合并胆管细胞癌、肝细胞癌和肝内胆管细胞癌术后的临床特征和预后因素:倾向评分匹配分析。
Int J Med Sci. 2021 Jan 1;18(1):187-198. doi: 10.7150/ijms.50883. eCollection 2021.
8
Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002).犬巨大肝细胞癌:48例(1992 - 2002年)
J Am Vet Med Assoc. 2004 Oct 15;225(8):1225-30. doi: 10.2460/javma.2004.225.1225.
9
Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study.犬巨大肝细胞癌的流行病学:一项4年回顾性研究。
Vet J. 2019 Jun;248:74-78. doi: 10.1016/j.tvjl.2019.04.011. Epub 2019 Apr 24.
10
Hepatocellular carcinoma in a young dog.一只幼犬的肝细胞癌
Can Vet J. 2013 Sep;54(9):845-8.

引用本文的文献

1
Overexpression of MCL-1 in canine hepatocellular carcinoma and its efficacy as a prognostic marker.MCL-1在犬肝细胞癌中的过表达及其作为预后标志物的效能
BMC Vet Res. 2025 May 16;21(1):349. doi: 10.1186/s12917-025-04798-6.
2
Early Enhancement in Contrast-Enhanced Computed Tomography Is an Index of , , , and Expression in Canine Hepatocellular Carcinoma: A Preliminary Study.对比增强计算机断层扫描中的早期强化是犬肝细胞癌中、、、和表达的一个指标:一项初步研究。
Vet Sci. 2025 Feb 7;12(2):137. doi: 10.3390/vetsci12020137.
3
Predictive Factors for Two-Year Survival in Dogs with Hepatobiliary Diseases: Importance of Clinical and Laboratory Monitoring.

本文引用的文献

1
Outcomes and prognostic variables associated with central division hepatic lobectomies: 61 dogs.与肝中叶切除术相关的结果和预后变量:61只犬。
Vet Surg. 2019 Apr;48(3):309-314. doi: 10.1111/vsu.13164. Epub 2019 Jan 20.
2
Incidence of blood transfusion requirement and factors associated with transfusion following liver lobectomy in dogs and cats: 72 cases (2007-2015).犬猫肝叶切除术后输血需求的发生率及与输血相关的因素:72例病例(2007 - 2015年)
J Am Vet Med Assoc. 2017 Oct 15;251(8):929-934. doi: 10.2460/javma.251.8.929.
3
Impact of surgical margins on survival of 37 dogs with massive hepatocellular carcinoma.
肝胆疾病犬两年生存的预测因素:临床和实验室监测的重要性
Animals (Basel). 2023 Aug 20;13(16):2677. doi: 10.3390/ani13162677.
4
Lymphopenia predicts reduced survival in canine hepatocellular carcinoma.淋巴细胞减少症预测犬肝细胞癌患者生存时间缩短。
J Vet Sci. 2023 May;24(3):e36. doi: 10.4142/jvs.22266.
5
Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs.比较肿瘤学:人类和犬类肝脏肿瘤的管理
Vet Sci. 2022 Sep 8;9(9):489. doi: 10.3390/vetsci9090489.
6
Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case-control study.复发性巨大肝细胞癌犬的风险因素和预后:兽医外科肿瘤学会病例对照研究。
Vet Comp Oncol. 2022 Sep;20(3):697-709. doi: 10.1111/vco.12824. Epub 2022 May 15.
手术切缘对37只患有巨大肝细胞癌犬类生存的影响。
N Z Vet J. 2017 Sep;65(5):227-231. doi: 10.1080/00480169.2017.1319304. Epub 2017 May 8.
4
Factors associated with long-term survival in dogs undergoing liver lobectomy as treatment for liver tumors.接受肝叶切除术治疗肝肿瘤的犬长期存活相关因素。
Can Vet J. 2015 Jun;56(6):598-604.
5
Triple-phase helical computed tomography in dogs with hepatic masses.患有肝脏肿块的犬的三相螺旋计算机断层扫描
Vet Radiol Ultrasound. 2014 Jan-Feb;55(1):7-15. doi: 10.1111/vru.12099. Epub 2013 Sep 18.
6
Classification of primary hepatic tumours in the dog.犬原发性肝脏肿瘤的分类。
Vet J. 2013 Sep;197(3):596-606. doi: 10.1016/j.tvjl.2013.05.027. Epub 2013 Sep 5.
7
The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer.术前血清白蛋白水平与美国麻醉医师协会(ASA)评分与接受根治性膀胱切除术的尿路上皮膀胱癌患者早期并发症和生存的关系。
BJU Int. 2014 Jun;113(6):887-93. doi: 10.1111/bju.12240. Epub 2013 Jul 26.
8
Accuracy of US-guided FNA of focal liver lesions in dogs: 140 cases (2005-2008).超声引导下犬肝脏局灶性病变细针穿刺抽吸活检的准确性:140例病例(2005 - 2008年)
J Am Anim Hosp Assoc. 2013 May-Jun;49(3):190-6. doi: 10.5326/JAAHA-MS-5851. Epub 2013 Mar 27.
9
CT characteristics of primary hepatic mass lesions in dogs.犬原发性肝脏肿块病变的CT特征
Vet Radiol Ultrasound. 2012 May-Jun;53(3):252-7. doi: 10.1111/j.1740-8261.2011.01917.x. Epub 2012 Jan 15.
10
Contrast-enhanced ultrasound in the detection and characterization of liver tumors.超声造影在肝脏肿瘤检测和诊断中的应用。
Cancer Imaging. 2009 Nov 6;9(1):96-103. doi: 10.1102/1470-7330.2009.0015.